New research reveals the shingles vaccine may cut vascular dementia risk by half, offering unexpected brain protection beyond preventing painful rash outbreaks.

While childhood programs have progressed, adult vaccine coverage remains low in India. From influenza and pneumococcal to HPV ...

The Primary Health Care Corporation (PHCC) has announced the availability of the Herpes Zoster Vaccine across all its health centers, ...

A second dose conferred an additional 67.9% effectiveness against any herpes zoster outcome. HealthDay News — Two doses of the recombinant zoster vaccine (RZV) are effective in older adults, including ...

The shingles vaccine is intended to prevent shingles, a painful rash caused by the reactivation of the varicella-zoster virus, also known as herpes zoster, but a new study suggests that it could have ...

Key market opportunities in the shingles vaccine sector include rising elderly populations; expanding healthcare ...

The global vaccines market is projected to grow from USD 50.46 billion in 2025 to USD 63.66 billion by 2030, achieving a CAGR of 4.8%. Key drivers include high rates of infectious diseases, ...

This recommendation follows a new study suggesting that the shingles vaccine may do more than just prevent a painful viral rash — it could also significantly reduce the risk of heart disease, dementia ...

Alerts have been issued about the rising number of chickenpox cases in Northern New South Wales this year. Meanwhile, ...

Two doses of the recombinant zoster vaccine are effective in older adults, including immunocompromised adults.